D. Hebebrand et al., ADENOVIRAL GENE-TRANSFER - AN ALTERNATIVE IMMUNOTHERAPY IN PERIPHERALXENOTRANSPLANTATION, Langenbecks Archiv fur Chirurgie, 1996, pp. 61-65
In this model of isolated limb perfusion the persistence and distribut
ion of adenoviral vectors were evaluated. Following perfusion for 90 m
inutes in muscle tissue intensity of gene expression of a beta-galakto
sidase marker gene was found to be highest after 48 hours. The persist
ence of the gene could be shown for 21 days. Although nerve tissues de
monstrated a lower transfection rate there were still 79% positive for
the control vector. The widespread of gene expression could be shown
in all tissues with a maximum in and around the vessles. The insertion
of sequences in the vascular system and muscles by adenoviral vectors
encoding for immunomodulating cytokines, inhibitory proteins or monoc
lonal antibodies might improve the results of xenotransplantation.